You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for ORASONE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ORASONE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free P6254_SIGMA ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free P1276 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-001-740-041 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-11112 ⤷  Get Started Free
Enamine ⤷  Get Started Free EN300-52605 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005267096 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS007930684 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for ORASONE

Last updated: August 1, 2025

Introduction

Orasone, also known by its chemical name Prednisolone Acetate, is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is used widely in ophthalmology, dermatology, rheumatology, and other medical indications. The pharmaceutical industry relies heavily on high-quality bulk Active Pharmaceutical Ingredients (APIs) like Orasone for drug manufacturing. Securing reliable API sources is critical for ensuring product quality, regulatory compliance, cost efficiency, and supply chain stability. This report examines global API vendors, quality considerations, regulatory status, and procurement strategies pertinent to Orasone.


Overview of Orasone (Prednisolone Acetate) as API

Prednisolone acetate is a modified corticosteroid designed for topical and systemic formulations. Its API form must meet stringent purity, stability, and bioavailability standards, conforming to pharmacopoeial specifications such as those of the USP, BP, or EP. The synthesis involves multi-step chemical processes, often utilizing raw materials sourced from multiple suppliers, emphasizing the importance of supplier reliability and compliance.


Global API Manufacturers for Orasone

1. Major Domestic and International API Suppliers

Numerous pharmaceutical ingredient manufacturers globally produce Prednisolone Acetate, including both established multinational corporations and regionally focused producers. Some prominent manufacturers include:

  • Piramal Enterprises Limited
    Based in India, Piramal offers high-grade APIs with global GMP certifications. Their APIs are characterized by consistent quality, extensive traceability, and scalable production capacities.

  • Mundipharma International GmbH & Co. KG
    A key player with comprehensive API manufacturing capabilities, especially for corticosteroids like Prednisolone derivatives, coupled with rigorous quality controls.

  • Tiger Pharmaceuticals
    An Indian API manufacturer with an established reputation for corticosteroid APIs, offering various forms of Prednisolone compounds, including acetate salts.

  • Sandoz (Novartis)
    As a global leader in generics, Sandoz produces high-quality APIs and possesses a robust quality assurance infrastructure compliant with international standards.

  • Hubei Zizhu Pharmaceutical Co., Ltd. (China)
    Focused on corticosteroid APIs, Zizhu supplies Prednisolone acetate, adhering to GMP standards and international pharmacopoeial quality.

2. Regional API Suppliers

  • India
    Countries like India have a thriving pharmaceutical API sector driven by domestic giants (e.g., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla) that produce Prednisolone acetate in compliance with global standards.

  • China
    Several companies, including Shanghai Huangpu Pharmaceutical Co., Ltd. and Hengkang Biological Technology, manufacture corticosteroid APIs for export markets.

  • Europe and North America
    While fewer companies are dedicated API producers for corticosteroids in these regions, some contract manufacturing organizations (CMOs) collaborate with pharmaceutical companies to supply high-quality APIs.

3. Contract Manufacturing Organizations (CMOs)

CMOs such as Wuxi AppTec, Lonza, and Thermo Fisher Scientific facilitate API synthesis based on client specifications, often offering tailored processes that meet stringent regulatory standards. These organizations can be advantageous for companies seeking reliable, high-quality sourced APIs without in-house manufacturing.


Quality Considerations for API Sourcing

GMP Compliance and Certification

API sourcing mandates adherence to Good Manufacturing Practices (GMP), ensuring consistent product quality and regulatory compliance. Suppliers should possess valid certifications from authorities like USFDA, EMA, PMDA, or ICH.

Analytical and Certification Protocols

Batch-specific certificates of analysis should confirm API purity (>98%), heavy metal limits, residual solvents, residual reactants, and microbiological specifications. Analytical validation and stability data are vital for regulatory submissions.

Regulatory Status and Approvals

Assess vendor compliance with regulatory authorities, especially if APIs are destined for markets with rigorous approval pathways like the US (FDA), EU (EMA), or Japan (PMDA). Suppliers with WHO-GMP or equivalent certifications are preferred.

Supply Chain Reliability

Long-term partnerships with suppliers demonstrating stable manufacturing capacity, contingency plans, and consistent logging of quality deviations reduce supply disruptions.


Regulatory Landscape and Import Considerations

Regulatory authorities require detailed documentation for APIs, including:

  • Certificate of Analysis (CoA)
  • Certificate of Suitability (CEP) or Drug Master File (DMF)
  • Batch records and compliance audits

Importing APIs like Prednisolone acetate involves verifying supplier credentials, customs procedures, and adherence to local pharmaceutical standards.


Procurement Strategies

1. Global Supplier Evaluation

Procure from approved vendors with proven track records, transparent quality systems, and regulatory compliance. Establish auditing protocols to verify GMP adherence.

2. Regional Partnering

In regions where local manufacturing is reliable, such as India and China, partnering with regional suppliers reduces lead times and logistical costs.

3. Quality and Cost Balance

While cost considerations are significant, prioritizing quality and regulatory compliance mitigates the risk of recalls and regulatory penalties.

4. Supply Chain Diversification

Employ multiple sourcing channels to minimize risk concentrations, especially for high-volume requirements.


Emerging Trends and Future Outlook

The API market for corticosteroids like Prednisolone acetate is evolving with increased demand from biosimilar and generic markets. Advanced synthetic techniques, including greener manufacturing and process intensification, enhance API purity and reduce costs. Regulatory shifts toward stricter quality oversight compel suppliers to invest in robust quality management systems. Asia-Pacific, notably India and China, continues to dominate API manufacturing due to scale and cost competitiveness.


Key Takeaways

  • Global Supply Diversity: Main suppliers include Indian companies such as Aurobindo Pharma, Indian CMOs like Piramal, Chinese manufacturers like Hubei Zizhu, and European firms like Sandoz, all with GMP-certified facilities.

  • Quality and Regulatory Compliance: Prioritize suppliers with proven GMP certification, comprehensive analytical data, and regulatory approvals like FDA DMFs or CEPs.

  • Strategic Procurement: Maintain diversified supplier relationships, conduct regular audits, and establish strong contractual agreements to guarantee supply continuity and quality.

  • Market Trends: The corticosteroid API market is consolidating toward greener and more cost-effective synthesis routes, with increased regulatory scrutiny driving higher quality standards.

  • Supply Chain Resilience: Incorporate contingency planning and ongoing quality monitoring to mitigate risks associated with geopolitical or logistical disruptions.


FAQs

1. What are the key factors in selecting an API supplier for Orasone?
Selection hinges on GMP compliance, regulatory approvals, consistent quality, supply capacity, certification credentials, and cost-effectiveness.

2. Are there regional differences in API quality standards for Prednisolone acetate?
Yes. While GMP standards are globally recognized, some regions may have varying regulatory enforcement. Suppliers with international certifications (e.g., USFDA, EMA) ensure compliance across markets.

3. How do I verify the quality of APIs before procurement?
Request comprehensive Certificates of Analysis, review batch records, audit manufacturing facilities when feasible, and validate analytical testing methods against pharmacopoeial standards.

4. What role do CMOs play in API sourcing for Prednisolone acetate?
CMOs offer custom synthesis, scale-up capabilities, and compliance assurance, facilitating flexible sourcing options especially for large-volume or specialized formulations.

5. Is China a reliable source for Prednisolone acetate APIs?
Many Chinese manufacturers comply with international GMP standards. Due diligence, audit reports, and certifications are necessary to confirm reliability and regulatory compliance.


References

  1. United States Pharmacopeia (USP), USP Monograph for Prednisolone Acetate.
  2. European Pharmacopoeia, Ph. Eur. Monograph for Prednisolone Acetate.
  3. W. Wu et al., "Advances in corticosteroid API synthesis," Journal of Pharmaceutical Development, 2021.
  4. International Conference on Harmonisation (ICH), Guidelines for Pharmaceutical Quality Assurance.
  5. Company websites and public filings of Piramal, Sandoz, Aurobindo, and Chinese pharmaceutical manufacturers cited herein.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.